Log In
Print
BCIQ
Print
Print this Print this
 

rebastinib (DCC-2036)

  Manage Alerts
Collapse Summary General Information
Company Deciphera Pharmaceuticals LLC
DescriptionBCR-ABL tyrosine kinase inhibitor
Molecular Target BCR-ABL tyrosine kinase
Mechanism of ActionBCR-ABL tyrosine kinase inhibitor
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today